Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,266,911
+$913,939 QoQ
Shares Held
50,087
-1.5% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#174
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OSAIC HOLDINGS, INC. holds $237,726,632 across 405 Biotechnology names. CYTK ranks #13 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
90,236 | $28,522,697 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,586 | $24,630,851 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
372,588 | $20,469,983 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
217,577 | $16,205,134 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
176,973 | $13,851,674 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
45,298 | $13,636,055 | |
| 7 | VCEL |
Vericel Corp
|
182,038 | $8,098,869 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,423 | $7,746,234 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,266,911 | 50,087 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,352,972 | 50,872 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,331,783 | 52,436 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,008,124 | 54,733 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $195,365 | 5,913 | Shares | Defined | 2025-09-04 | |
| 2025-03-31 | $204,164 | 5,080 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $259,382 | 5,749 | Shares | Defined | 2025-06-06 | |
| 2024-09-30 | $289,816 | 5,489 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $136,261 | 2,515 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $195,115 | 2,783 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $547,609 | 6,559 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $204,303 | 6,935 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $178,135 | 5,461 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $182,529 | 5,187 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $242,202 | 5,286 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $466,717 | 9,633 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $989,556 | 25,186 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $154,343 | 5,930 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $235,329 | 5,163 | Shares | Defined | 2022-02-03 | |
| 2021-09-30 | $149,535 | 4,184 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $81,079 | 4,097 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $90,736 | 3,901 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $56,625 | 2,725 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $29,941 | 1,383 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $32,596 | 1,383 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $17,554 | 1,489 | Shares | Defined | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||